Global Endocrine Testing Market, By Test (Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Human Chorionic Gonadotropin, Prolactin, Cortisol DHEA-S, Others) By Diagnostic Technology ( Immunoassay, Tandem Mass Spectrometry, Monoclonal and Polyclonal antibodies, Sensors Technologies, Clinical Chemistry , Others), By End User (Hospitals and Diagnostic Laboratories, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 3,403.0 million in 2020 and is expected to exhibit a CAGR of 5.3 % over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Key companies are focusing on product developments for testing of diabetes mellitus, one of the most common endocrinal disorders, globally. For instance, in 2018, Roche Diabetes Care India, a leading company in monitoring diabetes with their testing kits, launched a novel self- monitoring glucometer Accu-Chek Instant S for testing of glucose levels in blood of diabetic patients.
Moreover, companies are highly focused on innovation and advancements in rapid testing and diagnosis of diabetes to strengthen their market share in the global endocrine testing market. For instance, in 2019, iQ Group Global launched an innovative technology in saliva based glucose testing for diagnosis and testing the glucose level in blood.
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1755
Global Endocrine Testing Market – Impact of Coronavirus (Covid-19) Pandemic
Due to the lockdown, diabetic patients are unable to visit diagnostic laboratories due to risk of diabetic patients getting infected by COVID-19 infections. Therefore, safety procedures such as maintaining social distancing, proper management of blood spills while collecting blood samples, and use of personal protection equipment must be followed and evaluated for patients having diabetic conditions, as diabetic patients are more prone towards the risk of COVID-19 infection..
According to Journal of Reproductive Science report in 2020, fundamental principles such as social distancing and use of personal protection equipment should be followed by clinicians of diagnostics laboratories while performing testing procedures on patients
According to Indian Society of Assisted Reproduction report in 2020, while conducting semen analysis, it should be ensured that the male candidate is COVID-19 negative by reverse transcription polymerase chain reaction (RT-PCR)
Browse 45 Market Data Tables and 35 Figures spread through 200 pages and in-depth TOC on “Global Endocrine Testing Market, By Test ( Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Human Chorionic Gonadotropin, Prolactin, Cortisol DHEA-S, Others) By Diagnostic Technology ( Immunoassay, Tandem Mass Spectrometry, Monoclonal and Polyclonal antibodies, Sensors Technologies, Clinical Chemistry , Others), By End User (Hospitals and Diagnostic Laboratories, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),
Browse Research Report: https://www.coherentmarketinsights.com/market-insight/endocrine-testing-market-1755
The market is expected to gain significant growth during the forecast period, as various companies are focusing on research and development in the field of endocrine testing.
For instance, in 2018, MiraCare launched TechCrunch Disrupt SF, a novel self-monitoring fertility testing device for women who are suffering from fertility problems. TechCrunch Disrupt SF is a personalized self-monitoring device used for cycle predication in women by monitoring fertility hormone through urine samples in females.
Key Takeaways of the Global Endocrine Testing Market:
The global endocrine testing market is expected to exhibit a CAGR of 5.3 % over the forecast period, owing to robust product pipeline, and increasing approval of new endocrine testing devices and diagnostic procedures
Among test , insulin and thyroid segments are estimated to hold dominant position in the endocrine testing market in 2020, owing to rising prevalence of diabetes and thyroid related disorders (hypothyroidism and hyperthyroidism)
Among diagnosis technology type, sensor technologies endocrine testing market segment is estimated to hold dominant position in the endocrine testing market in 2020, due to rise technological advancements and increasing prevalence of endocrine related disorders
Among end user, diagnostic laboratories market segment is estimated to hold dominant position in the endocrine testing market in 2020, owing to rising diagnostic procedures due to high number of individuals suffering from fertility, diabetes, and thyroid related conditions
Key players operating in global endocrine testing market include Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Beckmann Coulter, Inc., Agilent Technologies, Inc, Siemens Healthineers AG, BioMérieux SA, Quest Diagnostics, and F. Hoffmann-La Roche AG.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1755
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737